semaglutide and ra GLP-1 medications found to be safe effective for treating obesity in adults with mental illness GLP-1 and Inflammation: How These

Physiol 307 , H165H172 (2014)

Adverse events served as a secondary endpoint

Warning signs that require prompt assessment include: Persistent vomiting that prevents adequate fluid or medication intake Inability to maintain nutrition or hydration Severe abdominal pain (which could indicate pancreatitis, gallbladder disease, or other serious conditions) Vomiting of undigested food consumed many hours previously Significant unintended weight loss Worsening glycaemic control despite medication adherence It is worth noting that symptoms alone cannot definitively distinguish between expected medication effects and true gastroparesis

Diabetes/Obesity (GLP-1) Drugs: Novo Nordisks GLP-1 agonists rank extremely high

Pellegrino says